Senior Director
Akebia Therapeutics
Senior Director
Akebia Therapeutics
Develops CKD anemia therapies
The RQA Senior Director is a strategic leadership role responsible for management of day-to-day GCP/GLP/GVP Quality Operations including, goal setting, budgeting, hiring, team development, strategic execution and oversight of the Akebia RQA operational strategy. This position will be a member of the Quality Leadership Team and will report to the Vice President (VP)/Sr. Vice President (SVP) of Quality.
This individual will oversee, assess, and directly work to continuously improve Research and Development Quality processes at Akebia. This is an opportunity to continue the development of the GCP/GLP/GVP QA function and ensure high quality execution of non-clinical and clinical trials from first in human through commercial marketing authorization.
This position will also be responsible for interactions with regulatory agencies in regard to GCP, GVP and GLP matters.
Essential Functions and Duties
Basic Qualifications
Preferred Qualifications
Base Compensation for this role will depend on a number of factors including a candidate’s qualifications, skills, competencies, and experience, and may fall outside of the range shown. Base pay is only one component of the company’s total rewards package, all regular employees are also eligible for the corporate bonus program or the incentive compensation program (if applicable), as well as equity. Additional benefits include health care, vision, dental, retirement, PTO, etc.
Targeted Base Salary 239153 - 295424 USD
Develops CKD anemia therapies
Akebia Therapeutics focuses on developing and commercializing therapies for chronic kidney disease (CKD), especially anemia related to CKD. Its lead product candidate, vadadustat, is in global Phase 3 trials. The company conducts research, clinical development, and strategic partnerships to bring therapies to market, generating revenue from product sales, licensing, and collaborations. Akebia's goal is to improve the quality of life for CKD patients by providing effective treatments through a science-driven biopharmaceutical approach based in Cambridge, MA.
Explore more opportunities at Akebia Therapeutics